Insider Trading History of Colvin Paul

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Colvin Paul since 2011. This trader's CIK number is 1513900. At the time of last reporting, Colvin Paul was the Pres., Clinical Solutions of Syneos Health, Inc.. (stock ticker symbol SYNH). Also see all insider trading activities at Syneos Health, Inc..

Note that in the past COLVIN PAUL also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Syneos Health, Inc. (SYNH) by Colvin Paul

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 SYNH 0 $0 8,486 $634,922 0 $0
2020 SYNH 1,300 $47,645 0 $0 0 $0

Yearly summary of insider trading at Pharmaceutical Product Development Inc (PPDI) by Colvin Paul

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 PPDI 0 $0 6,359 $182,689 6,359 $128,394


Insider trading activities at 2 companies by Colvin Paul:

1. Syneos Health, Inc. (SYNH)

2. Pharmaceutical Product Development Inc (PPDI)

Table 1. Insider trading of Syneos Health, Inc. (SYNH) by Colvin Paul

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-02-01 SYNH Sale 8,486 74.82 634,922
2020-03-19 SYNH Buy 1,300 36.65 47,645

Table 2. Insider trading of Pharmaceutical Product Development Inc (PPDI) by Colvin Paul

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-05-27 PPDI Sale 5,659 28.70 162,413
2011-05-26 PPDI Sale 100 28.70 2,870
2011-05-27 PPDI Option Ex 5,659 20.20 114,283
2011-05-26 PPDI Option Ex 100 19.94 1,994
2011-05-20 PPDI Sale 600 29.01 17,406
2011-05-20 PPDI Option Ex 600 20.20 12,117

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Colvin Paul (Pres., Clinical Solutions of Syneos Health, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.